Schepers, Robin
Gözlügöl, Nasir
Zeimpekis, Kostantinos
Bregenzer, Carola Maria
Gräni, Christoph
Afshar-Oromieh, Ali
Rominger, Axel
Caobelli, Federico
Article History
Received: 23 January 2024
Accepted: 21 August 2024
First Online: 18 September 2024
Declarations
:
: The authors declare no competing interests.
: Robin Schepers has received speaker honoraria from Siemens. Christoph Gräni receives funding from the Swiss National Science foundation, InnoSuisse, CAIM foundation, GAMBIT foundation and Novartis biomedical research foundation, outside of the submitted work. Axel Rominger has received research support and speaker honoraria from Siemens. Federico Caobelli is currently supported by a research grant by Siemens Healthineers and receives speakers Honoraria by Bracco AG and Pfizer AG for matters not related to the present manuscript. All other authors have no competing interests to disclose.